What changed in ten years and what is newly possible or cheap — pediatric obstructive sleep apnea testing

1. Summary

FDA's home-sleep-testing product code (MNR, "Ventilatory Effort Recorder") shows an accelerating clearance pace over the ten-year window queried here: 21 clearances in the window's first five years (2016-09-04 to 2021-09-03) versus 35 in its second five years (2021-09-04 to 2026-09-02) [1]. The underlying hardware has diversified sharply over that same window — from multi-channel ambulatory belts toward single-sensor rings, adhesive patches, and contactless radar, several paired with a deep-learning scoring layer rather than a fixed rule-based algorithm [7][9]. Age eligibility has not diversified at the same pace: of five specific 510(k) indications read for this report, one names a pediatric population outright, one extends most (not all) outputs to age 12, and three remain adult-only [2][3][4][5][6]. Two independently published evidence reviews — one on pediatric portable sleep monitors and one a UK health-technology-assessment economic review spanning both age groups — each conclude that pediatric-specific evidence remains too thin to support either stand-alone limited-channel use or a cost-effectiveness judgment [7][14]. Public annotated pediatric sleep datasets and automated staging algorithms did not exist in this form a decade ago and are now being used to train and benchmark scoring models, though none is validated as an independent diagnostic tool in children under 2 [11][12]. Two low-cost adjuncts — parent-recorded smartphone video scoring and questionnaire-plus-oximetry combinations — show promising sensitivity but modest specificity in small pediatric cohorts and have not been evaluated for cost-effectiveness [13][14].

2. What Changed

_Baseline (v1). No prior version; this establishes the starting point for future diffs._

3. Details

Clearance pace and the persistent age-indication gap

FDA's openFDA device/510(k) database lists 56 clearances in product code MNR decided between 2016-09-04 and 2026-09-02. Splitting that window at its exact midpoint (2021-09-03) puts 21 clearances in the first half and 35 in the second — the pace nearly doubled [1]. Against that volume, the age-eligibility language on the indications read for this report has moved only narrowly. The SNAP Diagnostics SAM Model 9-10000 (K240100, decided 2024-06-04) states, verbatim: "Both pediatric and adult patients may be tested. Use of this device must be under the direct supervision of a qualified adult (parent or guardian) or health care practitioner" [2]. The newest software update to the WatchPAT platform, WatchPAT SW (K254042, decided 2026-07-31), reads: "Central indices are indicated for use in patients 17 years and older. All other outputs are indicated for 12 years and older" [3] — a machine-scoring update to existing hardware that extends most, not all, outputs down to 12, unchanged from the age split this platform's earlier K223675 clearance already carried. Three devices cleared 2023-2025 remain adult-only in the language read directly from their summaries: Happy Health Home Sleep Test, "individuals who are 22 years of age or older" [4]; Withings Sleep Rx, "home-screening of adults with suspected possible sleep breathing disorders" [5]; and Belun Sleep System BLS-100, "adult patients suspected of sleep apnea" [6] — the same commercial ring later validated off-label in children by an independent research group, discussed below [8].

Sensor hardware: from multi-channel belts toward rings, patches, and radar

A 2024 systematic review of type III and IV portable sleep monitors in children (62 studies of 1,054 screened) found type III (multi-channel) monitors "repeatedly demonstrated higher diagnostic accuracies" than type IV (1-2 channel) devices, concluding "current evidence is limited to support the stand-alone use of type IV PSM for the diagnosis of sleep apnea in most children" [single-source, 7]. Set against that finding, two device categories not addressed in that review have since published pediatric validation data. A finger-worn ring (the manufacturer-cleared-adult-only Belun Sleep System, above) was evaluated against polysomnography in 75 Thai children aged 5-18 (June 2023-February 2024): Belun-derived AHI correlated moderately with PSG AHI (r=.63, mean difference -7.8 events/h, SD 13.91), and its area under the ROC curve for identifying moderate-to-severe OSA (PSG AHI >5) was 0.66 [single-source, 8]. A contactless millimeter-wave radar device (QSA600, paired with pulse oximetry and a deep-learning model) was evaluated against simultaneous polysomnography in 281 children aged 1-18 at Beijing Children's Hospital (September-November 2023): intraclass correlation for obstructive AHI was 0.945 (95% CI 0.93-0.96), with sensitivity/specificity of 81.8%/90.5%, 84.3%/95.3%, and 89.7%/97.1% for OAHI thresholds of >1, >5, and >10 events/h respectively [single-source, 9]. No US 510(k) record was located under the device name "QSA600" by this pass; the manufacturer was not named in the retrieved abstract, so this is not an exhaustive check of the registry for the underlying company.

Automated scoring and new pediatric datasets

A comparison of the publicly available U-Sleep automated staging algorithm against manual scoring in 56 children aged 6-17 found an overall F1 score of 0.75, 83.9% accuracy, and a kappa of 0.77 against expert scorers [single-source, 10]. That kind of external validation is newly possible partly because of infrastructure that did not exist a decade ago: the Boston Children's Hospital Sleep Corpus, published in 2025, is a public dataset of 15,695 annotated overnight polysomnograms from 12,640 unique pediatric patients (16.7 million annotated sleep stages, 139,208 hours of EEG) [single-source, 11]. A 2026 scoping review of AI in sleep diagnostics for children under 2 years old, however, found "no AI tool is validated for independent diagnostic use in this age group," noting that "commercial platforms such as SleepImage, Belun Sleep Health and WatchPAT exclude children under 2 years, while consumer monitors including Owlet, Nanit and Miku are widely used but lack clinical validation" [single-source, 12].

Newly cheap screening adjuncts, and the economic-evidence gap

A 41-child study of parent-recorded home video clips scored with the Monash OSA score found 81.2% sensitivity/52.0% specificity for any OSA and 100% sensitivity/44.4% specificity for moderate-severe OSA; combining the video score with a 3% oxygen-desaturation index raised the AUC to 98.3 for moderate-severe detection [single-source, 13]. A 2026 UK National Institute for Health and Care Research health-technology-assessment review of six novel home-testing devices — covering both adults and children — reported that "only three studies included children, and all of these were done in the clinic rather than the home setting," and concluded "there is insufficient evidence to assess the cost-effectiveness of novel home devices in children" even though, for adults, all six devices modeled were cheaper than home respiratory polygraphy and cost-effective against oximetry at conventional thresholds [single-source, 14].

One registered US pediatric technology-comparison trial

ClinicalTrials.gov NCT03473548, "Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients," sponsor Washington University School of Medicine, enrolled 11 children aged 5-12 (actual) and completed in 2024; the registry marks hasResults=true, but a WebFetch of the results tab returned only page-navigation content, no posted figures — recorded here as not retrieved, not as a finding either way [15].

4. Sources

[1] openFDA device/510(k) database, product code MNR "Ventilatory Effort Recorder" (continuously updated; queried window 2016-09-04 to 2026-09-02; accessed 2026-09-01). K163696–K254042, 21 CFR 868.2375 — https://api.fda.gov/device/510k.json?search=product_code:MNR [federal-registry] [2] FDA 510(k) Summary K240100 — SNAP Diagnostics SAM Model 9-10000, Snap Diagnostics, LLC (decided 2024-06-04; accessed 2026-09-01). K240100 — https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240100.pdf [federal-registry] [3] FDA 510(k) Summary K254042 — WatchPAT SW, Itamar Medical, Ltd. (decided 2026-07-31; accessed 2026-09-01). K254042 — https://www.accessdata.fda.gov/cdrh_docs/pdf25/K254042.pdf [federal-registry] [4] FDA 510(k) Summary K242224 — Happy Health Home Sleep Test, Happy Health, Inc. (decided 2025-06-18; accessed 2026-09-01). K242224 — https://www.accessdata.fda.gov/cdrh_docs/pdf24/K242224.pdf [federal-registry] [5] FDA 510(k) Summary K231667 — Withings Sleep Rx, Withings (decided 2024-09-06; accessed 2026-09-01). K231667 — https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231667.pdf [federal-registry] [6] FDA 510(k) Summary K222579 — Belun Sleep System BLS-100, Belun Technology Company Limited (decided 2023-02-23; accessed 2026-09-01). K222579 — https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222579.pdf [federal-registry] [7] PMID 39173472 — "Diagnostic accuracy of portable sleep monitors in pediatric sleep apnea: A systematic review," Sleep Medicine Reviews (published 2024, month/day not given in the PubMed record; accessed 2026-09-01). PMID 39173472 — https://pubmed.ncbi.nlm.nih.gov/39173472/ [peer-reviewed] [8] PMID 39297539 — Panichapat N et al., "Diagnostic accuracy of the Belun ring in children at risk of obstructive sleep apnea," Journal of Clinical Sleep Medicine 2025;21(1):123-128 (published 2025-01-01; accessed 2026-09-01). PMID 39297539 — https://pubmed.ncbi.nlm.nih.gov/39297539/ [peer-reviewed] [9] PMID 40738779 — "Deep learning-based automated diagnosis of obstructive sleep apnea and sleep stage classification in children using millimeter-wave radar and pulse oximeter," Sleep Health (published 2025-12, day not given in the PubMed record; accessed 2026-09-01). PMID 40738779 — https://pubmed.ncbi.nlm.nih.gov/40738779/ [peer-reviewed] [10] PMID 40036779 — "Artificial intelligence or sleep experts: comparing polysomnographic sleep staging in children and adolescents," Sleep (published 2025-07-11; accessed 2026-09-01). PMID 40036779 — https://pubmed.ncbi.nlm.nih.gov/40036779/ [peer-reviewed] [11] PMID 40971987 — "The Boston Children's Hospital Sleep Corpus: A Collection of 15,695 Annotated Pediatric Polysomnograms," Sleep (published 2025-09-16; accessed 2026-09-01). PMID 40971987 — https://pubmed.ncbi.nlm.nih.gov/40971987/ [peer-reviewed] [12] PMID 42270115 — "Artificial intelligence in sleep diagnostics for children under 2 years of age: state of the evidence and future directions," European Respiratory Review (published 2026-04, day not given in the PubMed record; accessed 2026-09-01). PMID 42270115 — https://pubmed.ncbi.nlm.nih.gov/42270115/ [peer-reviewed] [13] PMID 40844073 — "Preliminary Estimates of the Diagnostic Accuracy of Video Clips for Obstructive Sleep Apnea in Children," Pediatric Pulmonology (published 2025-08, day not given in the PubMed record; accessed 2026-09-01). PMID 40844073 — https://pubmed.ncbi.nlm.nih.gov/40844073/ [peer-reviewed] [14] PMID 42661570 — "Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome - a systematic review and economic evaluation," Health Technology Assessment (Winchester, England), Vol. 30, No. 65, NIHR award NIHR135895 (published 2026-08, day not given in the PubMed record; accessed 2026-09-01). PMID 42661570 — https://pubmed.ncbi.nlm.nih.gov/42661570/ [peer-reviewed] [15] ClinicalTrials.gov NCT03473548 — "Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients," sponsor Washington University School of Medicine, status COMPLETED, hasResults=true, record last updated 2024-02-07 (accessed 2026-09-01). NCT03473548 — https://clinicaltrials.gov/study/NCT03473548 [trial-registry]

5. Sourcing & Gaps

Well established: The clearance count, date range, and product-code composition of the MNR roster [1], and the exact indications-for-use text of the five devices read directly [2][3][4][5][6], are each drawn straight from a single federal registry record — the canonical source for that fact — and are stated plainly rather than marked, matching how this domain's sibling reference-products report and dossier already treat individually-verified registry entries.

Thin: Every diagnostic-accuracy and cost finding in this report rests on exactly one published study or review and carries [single-source]: the type III/IV portable-monitor review [7], the Belun ring pediatric validation [8], the QSA600 radar study [9], the U-Sleep pediatric comparison [10], the BCH Sleep Corpus description [11], the under-2 AI scoping review [12], the video-clip screening study [13], and the NIHR economic review [14]. None of these has an independent second source corroborating the same specific quantity in this report. Two of the pediatric device-validation studies ([8], [9]) were conducted outside the US (Thailand and China respectively); the video-clip study's site country is not stated in the retrieved abstract [13].

Rescoped from class 3: None in this report. This report addresses only what devices and algorithms exist and what they measured in a study population, not what any stakeholder would choose to use.

Out of scope: CPT descriptors (AMA-licensed, not reproduced here). MAUDE complaint or failure-mode narratives for any device named (no connector reaches MAUDE in this repo). Device pricing for any HSAT device, ring, or consumer wearable named here (no connector and no pricing page was retrieved this pass). The PatentsView patent connector was not queried this pass, so no sensor- or algorithm-level patent landscape is represented here. Non-US and non-EU jurisdictions beyond the individual non-US studies cited above.

Not searched vs. not found: A US 510(k) record for the device name "QSA600" was searched for directly and not found (zero records); the underlying manufacturer's name was not retrieved from the abstract, so a search under the company name was not performed. The remaining 51 of 56 clearances in product code MNR (beyond the five read directly here) were not searched for pediatric-inclusive indication language this pass. NCT03473548's posted numeric results were not retrieved (WebFetch of the results tab returned navigation content only), as distinct from not having been searched for. A published, peer-reviewed report of the QSA600 study's results beyond the structured abstract was not searched.

[inference] The clearance-pace acceleration in a product code where nearly every newly labeled device remains adult-only suggests that the sensor and algorithm side of this market is innovating faster than the regulatory evidence base needed to extend indications to children — a synthesis of this report's own reading across sections 1 and 3, not a conclusion stated by any cited source.

6. Claim Candidates